Luke V. Blakeway
- Molecular Medicine top 5%
- Epidemiology
- Molecular Biology
- Microbiology top 10%
- Endocrinology top 10%
- Co-authors
- Kate L. SeibIan R. PeakAimee TanJane HawkeyAdam JenneyLouise M. JuddAnton Y. PelegKelly L. Wyres
- Topics
- Pneumonia and Respiratory Infections (9 papers)Antibiotic Resistance in Bacteria (9 papers)Bacterial Identification and Susceptibility Testing (6 papers)
- Partner nations
- AustraliaUnited StatesUnited Kingdom
In The Last Decade
Luke V. Blakeway
19 papers receiving 296 citations
Peers
Comparison fields: 5 of 51
- Molecular Medicine 121
- Epidemiology 94
- Molecular Biology 91
- Microbiology 57
- Endocrinology 47
Countries citing papers authored by Luke V. Blakeway
This map shows the geographic impact of Luke V. Blakeway's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luke V. Blakeway with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luke V. Blakeway more than expected).
Fields of papers citing papers by Luke V. Blakeway
This network shows the impact of papers produced by Luke V. Blakeway. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luke V. Blakeway. The network helps show where Luke V. Blakeway may publish in the future.
Co-authorship network of co-authors of Luke V. Blakeway
This figure shows the co-authorship network connecting the top 25 collaborators of Luke V. Blakeway. A scholar is included among the top collaborators of Luke V. Blakeway based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luke V. Blakeway. Luke V. Blakeway is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 1 | |
| 3 | 0 | |
| 4 | 0 | |
| 5 | 2 | |
| 6 | 12 | |
| 7 | 1 | |
| 8 | 1 | |
| 9 | 24 | |
| 10 | 39 | |
| 11 | 12 | |
| 12 | 7 | |
| 13 | 49 | |
| 14 | 2 | |
| 15 | 4 | |
| 16 | 0 | |
| 17 | 14 | |
| 18 | 14 | |
| 19 | 6 | |
| 20 | 63 |
About Luke V. Blakeway
Luke V. Blakeway is a scholar working on Molecular Medicine, Applied Microbiology and Biotechnology and Clinical Biochemistry, having authored 22 papers that have together received 298 indexed citations. Recurring topics across this work include Pneumonia and Respiratory Infections (9 papers), Antibiotic Resistance in Bacteria (9 papers) and Bacterial Identification and Susceptibility Testing (6 papers). The work is most often cited by research in Molecular Medicine (121 citations), Applied Microbiology and Biotechnology (19 citations) and Microbiology (57 citations). Luke V. Blakeway has collaborated with scholars based in Australia, United States and United Kingdom. Frequent co-authors include Kate L. Seib, Ian R. Peak, Aimee Tan, Jane Hawkey, Adam Jenney, Louise M. Judd, Anton Y. Peleg, Kelly L. Wyres, Ryan R. Wick and Kathryn E. Holt. Their work appears in journals such as Nature Communications, PLoS ONE and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.